Genetic analysis of pancreatic duct hyperplasia in Otsuka Long-Evans Tokushima Fatty rats: Possible association with a region on rat chromosome 14 that includes the disrupted cholecystokinin-A receptor gene
N. Kanemoto et al., Genetic analysis of pancreatic duct hyperplasia in Otsuka Long-Evans Tokushima Fatty rats: Possible association with a region on rat chromosome 14 that includes the disrupted cholecystokinin-A receptor gene, PATHOL INT, 51(3), 2001, pp. 133-139
An Otsuka Long-Evans Tokushima Fatty (OLETF) strain of rat spontaneously de
veloped hyperglycemia, hyperinsulinemia, insulin resistance and mild obesit
y, which had been studied as animal model for type II diabetes mellitus (T2
DM). Recently, we observed that this strain coincidentally developed atypic
al hyperplasia of the choledocho-pancreatic ductal epithelium with a comple
te incidence. In an effort to locate genes responsible for this hyperplasia
, we prepared 288 backcross progeny from a mating between OLETF rats and BN
rats (which do not develop hyperplasia), and performed a genome-wide scan
using 207 polymorphic genetic markers. We observed a prominent association
of hyperplasia with a region involving a marker locus D14Mit4 (P = 0.00020,
Fisher's exact test) and Cckar (the cholecystokinin-A receptor gene; P = 0
.00025, Fisher's exact test) which is known to be disrupted in an OLETF str
ain. Our findings indicated that epithelial hyperplasia of the choledocho-p
ancreatic duct is associated with a region on rat chromosome 14 around the
Cckar gene in an additive fashion with another two susceptible loci, each o
n chromosome 9 and 7. This implied the possibility that Cckar deficiency co
uld result in a predisposition towards pancreatic duct hyperplasia.